Market Movers: Ola Electric, CG Power Lead Corporate Action

Ola Electric raises ₹780 crore; CG Power expands Nashik capacity by 80%.

Reader Takeaway: QIPs fuel growth, while capacity expansion signals confidence; regulatory scrutiny remains a watch point.

What just happened

Ola Electric has raised ₹780 crore through a Qualified Institutional Placement (QIP) by allotting 21.8 crore shares at ₹35.9 per share. ACME Solar Holdings also completed a QIP, though the total capital raised was not disclosed.

CG Power & Industrial Solutions inaugurated a new EHV switchgear manufacturing unit in Nashik, increasing its capacity by 80%. Ambuja Cements received stock exchange approval for its merger with ACC. Juniper Hotels plans to develop a five-star hotel in New Delhi after acquiring a stake in related assets. Aurobindo Pharma secured final US FDA approval for Tofacitinib tablets. InterGlobe Aviation is optimizing its international flight network, suspending services to six destinations. One 97 Communications (Paytm) will provide default loss guarantees of up to ₹90 crore to two finance companies.

Why this matters

The QIP by Ola Electric provides significant capital for growth initiatives. CG Power's capacity expansion indicates strategic investment in manufacturing capabilities. The merger clearance for Ambuja Cements and ACC paves the way for consolidation. Aurobindo Pharma's US FDA approval opens up a new market for its arthritis medication.

The backstory

Ola Electric is a prominent player in the electric vehicle sector, continually seeking capital for expansion. CG Power is a key player in the industrial solutions space, focusing on power transmission and distribution equipment. Ambuja Cements and ACC are major cement producers in India. Aurobindo Pharma is a significant generic drug manufacturer with a strong global presence.

What changes now

Ola Electric is better positioned with enhanced capital for its operations and expansion plans. CG Power's increased capacity will allow it to cater to a larger market demand for EHV switchgear. Ambuja Cements and ACC will move towards integration, potentially leading to cost synergies.

Risks to watch

FDC faced a stock seizure of 'Enerzal' by Maharashtra FDA officials, with the company planning legal action. This highlights potential regulatory risks in the pharmaceutical sector. Global market volatility and US tech stock corrections also pose broader risks.

Peer comparison

Ambuja Cements and ACC are major players in the Indian cement industry. InterGlobe Aviation (IndiGo) competes in the domestic and international aviation sector. Aurobindo Pharma operates in the competitive pharmaceutical generics market.

Context metrics (04th June 2026)

Institutional investors showed mixed activity. Foreign Institutional Investors (FIIs) recorded a net outflow of ₹4,447.1 crore, while Domestic Institutional Investors (DIIs) had a net inflow of ₹4,360.1 crore in the cash market.

What to track next

Investors will be closely watching the upcoming RBI policy outcome and 4QFY26 GDP data for market direction. Updates on FDC's legal recourse and any further developments in regulatory inspections will be crucial.